Home Newsfeeds Compass Therapeutics Q2 EPS $(0.08) Up From $(1.07) YoY

Compass Therapeutics Q2 EPS $(0.08) Up From $(1.07) YoY

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.

byBenzinga Newsdesk

August 1, 2022

1 minute read

Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share. This is a 92.52 percent increase over losses of $(1.07) per share from the same period last year.

Mike Pence Says Trump Skipping Second GOP Debate A Missed Opportunity: ‘This Country Is In A Lot Of Trouble’

By Navdeep Yadav

September 20, 1:49 AM

Mike Pence has publicly criticized Donald Trump for opting out of the second GOP primary debate in the 2024 presidential race.

Be Ready: New AirPods Pro, Fresh Colors For AirPods Max Could Be Coming This Fall

By Shivdeep Dhaliwal

May 9, 7:21 AM

Updated AirPods Pro will launch in the fall alongside new colors for the AirPods Max over-the-ear headphones, according to Apple Inc (NASDAQ: AAPL)-focused journalist Mark Gurman.

AAPL

Why Dogecoin Is Getting Hammered

By Henry Khederian

April 6, 6:14 PM

Dogecoin (CRYPTO: DOGE) is trading lower by 7.95% to the $0.085-level Thursday. The meme crypto is falling sharply during Thursday evening trading after Twitter switched the website's logo from an image of a Shiba Inu, back to the classic blue bird.

$DOGE